Orion Oyj Eulerpool News

Orion Oyj Eulerpool News

Orion Oyj Stock News

Orion Oyj is being monitored by journalists and investors worldwide. We gather the latest Orion Oyj news here.

• September 30 ·

  Yahoo
  Orion’s near-term climate targets approved by the Science Based Targets initiative
• September 26 ·

  Yahoo
  Orion OYJ (ORINY) Is a Great Choice for 'Trend' Investors, Here's Why
• September 26 ·

  Yahoo
  Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
• September 26 ·

  GlobeNewswire
  Orion?s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbuster
• September 25 ·

  Yahoo
  Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
• September 20 ·

  Yahoo
  213,285 Orion Corporation A shares converted into B shares
• September 16 ·

  Yahoo
  Darolutamide plus androgen deprivation therapy significantly reduced the risk of radiological progression or death by 46% compared to placebo plus ADT in patients with metastatic hormone-sensitive prostate cancer
• September 11 ·

  Yahoo
  Inside information: Orion upgrades full-year outlook for 2024
• September 2 ·

  Yahoo
  3 Reasons Why Growth Investors Shouldn't Overlook Orion OYJ (ORINY)
• August 22 ·

  Yahoo
  Orion Corporation: Managers’ transactions – Satu Ahomäki